7,505 followers
Frontiers | BCR-ABL1 Doubling-Times and Halving-Times May Predict #CML Response to Tyrosine Kinase Inhibitors | Oncology https://t.co/oTG8ZFVsUf
Frontiers | BCR-ABL1 Doubling-Times and Halving-Times May Predict #CML Response to Tyrosine Kinase Inhibitors | Oncology https://t.co/oTG8ZFVsUf